We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
NGM Biopharmaceuticals Inc | NASDAQ:NGM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.54 | 1.54 | 1.35 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * COLUMN GROUP L P | 2. Issuer Name and Ticker or Trading Symbol NGM BIOPHARMACEUTICALS INC [ NGM ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 4/3/2020 | P | 14587 (1) | A | $12.41 | 1303741 | D (2)(3) | |||
Common Stock | 4/7/2020 | P | 123728 (4) | A | $14.38 | 1427469 | D (2)(3) | |||
Common Stock | 16166907 (5) | D (6)(7)(8)(9)(10)(11) | ||||||||
Common Stock | 15000 | D (12) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Remarks: Due to SEC restrictions on the number of reporting owners, this is Form 1 of 2. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
COLUMN GROUP L P 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
COLUMN GROUP II, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
COLUMN GROUP GP, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
Column Group Management LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
PONOI CAPITAL, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
Ponoi Management, LLC 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | General Partner | |||
Ponoi Capital II, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | ||||
Ponoi II Management, LLC 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | General Partner | |||
Kutzkey Tim 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | Managing Partner | |||
Column Group II GP, LP 1700 OWENS STREET SUITE 500 SAN FRANCISCO, CA 94158 | X | General Partner |
Signatures | ||
/s/ Jennifer J. Carlson, Attorney-in-Fact | 4/7/2020 | |
**Signature of Reporting Person | Date |
1 Year NGM Biopharmaceuticals Chart |
1 Month NGM Biopharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions